The Revolution in Treatment of Hepatitis C

被引:12
|
作者
Mayberry, Jordan [1 ]
Lee, William M. [1 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Div Digest & Liver Dis, Dallas, TX 75390 USA
关键词
Direct-acting antivirals; Sustained viral response; Hepatitis C virus; Protease inhibitors; Polymerase inhibitors; VIRUS; END;
D O I
10.1016/j.mcna.2018.08.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Treatment of hepatitis C with interferon therapy produced some cures early on, but was associated with significant side effects. Because of further advances in the molecular understanding of hepatitis C, by 2014 effective treatments became available that far surpassed all prior interferon-based regimens in efficacy, tolerability, and safety. This led to rapid transformation of a hard-to-treat disease to simple, safe, and effective treatment offered to anyone. This article focuses on hepatitis C epidemiology; the clinical impact and consequences; discussion of past hepatitis C treatments; and a review of current recommendations for screening, diagnosis, and treatment of this ubiquitous virus.
引用
收藏
页码:43 / +
页数:14
相关论文
共 50 条
  • [1] Revolution in hepatitis C antiviral therapy
    Sadler, Matthew D.
    Lee, Samuel S.
    BRITISH MEDICAL BULLETIN, 2015, 113 (01) : 31 - 44
  • [2] Elbasvir and grazoprevir for the treatment of hepatitis C
    Wang, Szu-Jen
    Huang, Chung-Feng
    Yu, Ming-Lung
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2021, 19 (09) : 1071 - 1081
  • [3] An update on direct antiviral agents for the treatment of hepatitis C
    Stanciu, Carol
    Muzica, Cristina Maria
    Girleanu, Irina
    Cojocariu, Camelia
    Sfarti, Catalin
    Singeap, Ana-Maria
    Huiban, Laura
    Chiriac, Stefan
    Cuciureanu, Tudor
    Trifan, Anca
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (13) : 1729 - 1741
  • [4] An Overview of Emerging Therapies for the Treatment of Chronic Hepatitis C
    Ilyas, Jawad A.
    Vierling, John M.
    CLINICS IN LIVER DISEASE, 2011, 15 (03) : 515 - +
  • [5] Progress in hepatitis C treatment
    Vinaixa, Carmen
    Aguilera, Victoria
    Berenguer, Marina
    MEDICINA CLINICA, 2013, 141 (10): : 447 - 452
  • [6] Beclabuvir for the treatment of hepatitis C
    Gentile, Ivan
    Zappulo, Emanuela
    Buonomo, Antonio Riccardo
    Maraolo, Alberto Enrico
    Borgia, Guglielmo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (08) : 1111 - 1121
  • [7] Acute hepatitis C treatment
    Lerias de Almeida, Paulo Roberto
    ANNALS OF HEPATOLOGY, 2010, 9 : S107 - S111
  • [8] Effectiveness of hepatitis C antiviral treatment and feasibility of hepatitis C elimination goal
    Burgui, Cristina
    San Miguel, Ramon
    Goni-Esarte, Silvia
    Juanbeltz, Regina
    Isidro Uriz-Otano, Juan
    Reparaz, Jesus
    Sarobe, Maite
    Manuel Zozaya, Jose
    Castilla, Jesus
    POSTGRADUATE MEDICINE, 2023, 135 (04) : 352 - 360
  • [9] Managing expense and expectation in a treatment revolution: Problematizing prioritisation through an exploration of hepatitis C treatment 'benefit'
    Harris, Magdalena
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 47 : 161 - 168
  • [10] Advances in Hepatitis C Treatment: At the Crossroads
    Lam, Jerika T.
    Yamaki, Jason
    Kayali, Zeid
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2015, 11 (07): : 669 - 679